Biochemistry, Biology, and Carcinogenicity of Tobacco-Specific <i>N</i>-Nitrosamines
Tóm tắt
Từ khóa
Tài liệu tham khảo
Druckrey, H., Preussmann, R., Ivankovic, S., and Schmähl, D. (1967) Organotrope Carcinogen Wirkungen bei 65 verschiedenen N-Nitrosoverbindungen an BD-ratten. (Organotropic carcinogenic effects of 65 different N-nitroso compounds on BD-rats.)Z. Krebsforsch.69, 103−201.
Preussmann R., 1984, Chemical Carcinogenesis
Lijinsky W., 1992, Chemistry and Biology of N−Nitroso Compounds
Druckrey H., 1962, Zur Entstehung carcinogener Nitrosamine am Beispiel des Tabakruachs. (The formation of carcinogenic nitrosamines in tobacco, as an example.) Die Natur. 49, 488−499
Boyland E., 1964, Br. J. Cancer, 18
Hoffmann D., 1974, IARC Scientific Publ. No. 9, 165
Hoffmann D., 1974, N‘-nitrosonornicotine in tobacco. Science 186, 265−267
Smith P. A. S., 1967, J. Am. Chem. Soc., 89
Klus H., 1975, Utersuchungen uber die nichtfluchtigen N-nitrosamine der tabakalkaloide. (Research on the non-volatile nitrosamines of tobacco alkaloids.) Fachliche Mitt. Austria Tabakwerke 16, 307−317
Hecht S. S., 1977, Beitr. Tabakforsch., 9, 6
Hecht S. S., 1976, Tetrahedron Lett., 8
Hecht S. S., 1980, N‘-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 40, 298−302.
International Agency for Research on Cancer., 1985, Tobacco habits other than smoking: betel quid and areca nut chewing and some related nitrosamines. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 37
International Agency for Research on Cancer., 1986, Tobacco smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 38
Hoffmann D., 1985, Nicotine-derived N-nitrosamines and tobacco related cancer: current status and future directions. Cancer Res. 45, 935−944
Hecht S. S., 1988, Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875−884
World Cancer Research Fund/American Institute for Cancer Research., 1997, Food, Nutrition and the Prevention of Cancer: a Global Perspective, 37
Anonymous, 1996, Cigarette smoking among adults − United States
National Institutes of Health, National Cancer Institute. (1996) Changes in cigarette-related disease risks and their implication for prevention and control.Smoking and Tobacco Control Monograph 8, pp 13−112, NIH, Bethesda, MD.
Thun M. J., 1997, J. Natl. Cancer Inst., 89
Shopland D. R., 1995, Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ. Health Perspect. 103 (Suppl. 8), 131−142
Fuchs, C. S., Colditz, G. A., Stampfer, M. J., Giovannucci, E. L., Hunter, D. J., Rimm, E. B., Willett, W. C., and Speizer, F. E. 593 (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer.Arch. Intern. Med.156, 2255−2260.
Hoffmann D., 1990, Handbook of Experimental Pharmacology
Hecht S. S., 1989, The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8, 273−294
Hecht S. S., 1991, Origins of Human Cancer: A Comprehensive Review
Idris A. M., 1991, Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis 12, 1115−1118
Magee P. N., 1989, The experimental basis for the role of nitroso compounds in human cancer. Cancer Surv. 8, 207−239
Preston-Martin S., 1989, Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv. 8, 459−473
Magee P. N., 1996, Eur. J. Cancer Prev., 5, 10
Bartsch H., 1996, Eur. J. Cancer Prev., 5, 18
Hecht S. S., 1983, J. Environ. Sci. Health, 1, 54
Shopland D., 1997, J. Natl. Cancer Inst., 84, 1573
Hecht S. S., 1980, Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Cancer Res. 40, 4144−4150
Castonguay A., 1983, Tissue distribution of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and its metabolites in F344 rats. Cancer Res. 43, 630−638
Carmella S. G., 1985, N‘-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Anal. Biochem. 145, 239−244.
Chung, F.L., Wang, M., and Hecht, S. S. (1985) Effects of dietary indoles and isothiocyanates onN-nitrosodimethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone α-hydroxylation and DNA methylation in rat liver.Carcinogenesis6, 539−543.
Devereux, T. R., Anderson, M. W., and Belinsky, S. A. (1988) Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and their relationship to carcinogenicity.Cancer Res.48, 4215−4221.
Liu L., 1990, Cancer Res. 50
Alaoui-Jamali M. A., 1991, Metabolism, sister chromatid exchanges, and DNA single-strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their modulation by vitamin A in vitro. Cancer Res. 51, 3946−3950
Alaoui-Jamali M. A., 1991, Protective effects of vitamin A against the genotoxicity of NNK, a nicotine-derived N-nitrosamine. Carcinogenesis 12, 379−384
Liu L., 1991, Inhibition of the metabolism and genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes by (+)-catechin. Carcinogenesis 12, 1203−1208
Demkowicz-Dobrzanski K., 1992, Modulation by glutathione of DNA strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes. Carcinogenesis 13, 1447−1454
Guo Z., 1992, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys. 298, 279−286
Guo Z., 1992, Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 13, 2205−2210
Guo, Z., Smith, T. J., Wang, E., Eklind, K. I., Chung, F.L., and Yang, C. S. (1993) Structure−activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice.Carcinogenesis14, 1167−1173.
Murphy S. E., 1993, Two type of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone hemoglobin adducts, from metabolites which migrate into or are formed in red blood cells. Cancer Res. 53, 777−783
Zhang Z., 1993, Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 13, 2341−2346
Peterson L. A., 1994, Formation of NADP(H) analogues of tobacco specific nitrosamines in rat liver and pancreatic microsomes. Chem. Res. Toxicol. 7, 599−608
Hamilton S. M., 1994, Effects of isothiocyanates on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene by hamster and rat liver microsomes. Anticancer Res. 14, 1089−1094
Murphy, S. E., Spina, D. A., Nunes, M. G., and Pullo, D. A. (1995) Glucuronidation of 4-(hydroxymethyl)nitrosamino-1-(3-pyridyl)-1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital treated rats.Chem. Res. Toxicol.8, 772−779.
Murphy S. E., 1997, NNK. Chem.-Biol. Interact. 103, 153−166.
Staretz, M. E., Koenig, L., and Hecht, S. S. (1997) Effects of long-term phenethyl isothiocyanate treatment on microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats.Carcinogenesis18, 1715−1722.
Lamoureux J., 1997, Carcinogenesis 18
Belinsky S. A., 1989, Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fisher rat. Carcinogenesis 10, 2269−2274
Doerr-O'Rourke K., 1991, Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue. Carcinogenesis 12, 1029−1034
Guo Z., 1991, Metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone as measured by DNA alkylation in vitro and its inhibition by isothiocyanates. Cancer Res. 51, 4798−4803
Smith T. J., 1992, Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis 13, 1409−1414
Brittebo E. B., 1983, Metabolism of tobacco specific nitrosamines by cultured rat nasal mucosa. Cancer Res. 43, 4343−4348
Hong J.-Y., 1991, Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. Cancer Res. 51, 1509−1514
Hong J.-Y., 1992, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P450s NMa and NMb. Carcinogenesis 13, 2141−2144
Eriksson C., 1996, 3-Aminobenzamide: effects on cytochrome P-450-dependent metabolism of chemicals and on the toxicity of dichlobenil in the olfactory mucosa. Toxicol. Appl. Pharmacol. 136, 324−331
Murphy S. E., 1990, Comparative metabolism of N‘-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat oral tissue and esophagus. Cancer Res. 50, 4685−4691
Murphy S. E., 1990, Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N‘-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue. Carcinogenesis 11, 1663−1666
Murphy S. E., 1991, Effect of phenethyl isothiocyanate on the metabolism of tobacco-specific nitrosamines by cultured rat oral tissue. Carcinogenesis 12, 957−961
Schulze J., 1995, Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: sex-difference, inducibility and inhibition by phenethylisothiocyanate. Carcinogenesis 16, 1733−1740
Tjälve, H., and Castonguay, A. (1983) The in vivo tissue disposition and in vitro target-tissue metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in Syrian golden hamsters.Carcinogenesis4, 1259−1265.
Jorquera R., 1992, Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes. Drug Metab. Dispos. 20, 510−517
Castonguay A., 1992, Vitro 6, 397−404.
Jorquera R., 1993, Effect of tobacco smoke condensate on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes. Drug Metab. Dispos. 21, 318−324
Miller C. H., 1994, Effects of compounds of plant origin on the mutagenicity and metabolism of the tobacco-specific nitrosamine NNK. Phytother. Res. 8, 342−347
Miller C., 1996, Modulation of the mutagenicity and metabolism of the tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds. Mutat. Res. 368, 221−233
Zhang, Z., Huynh, H., and Teel, R. W. (1997) Effects of orally administered capsaicin, the principal component of capsicum fruits, on the in vitro metabolism of the tobacco-specific nitrosamine NNK in hamster lung and liver microsomes.Anticancer Res.17, 1093−1098.
Rossignol G., 1989, Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster. Cancer Res. 49, 5671−5676
Charest M., 1989, vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in hamster lung tissues. Chem.-Biol. Interact. 71, 265−278
Alaoui-Jamali M. A., 1990, Cancer Lett., 52, 55
Schuller H. M., 1991, Cancer Res. 51
Schulze J., 1996, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by hamster, mouse and rat intestine: relevance of species differences. Carcinogenesis 17, 1093−1099
Castonguay A., 1984, J. Natl. Cancer Inst., 72
Morse, M. A., LaGreca, S. D., Amin, S. G., and Chung, F.L. (1990) Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice.Cancer Res.50, 2613−2617.
Peterson L. A., 1991, Quantitation of metabolic α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 51, 5495−5500
Lin, J.M., Desai, D. H., Morse, M. A., Amin, S., and Hecht, S. S. (1992) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol.Chem. Res. Toxicol.5, 674−679.
Hong, J.Y., Wang, Z. Y., Smith, T. J., Zhou, S., Shi, S., Pan, J., and Yang, C. S. (1992) Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung.Carcinogenesis13, 901−904.
Smith T. J., 1993, Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res. 53, 3276−3282
Castonguay, A., Lin, D., Stoner, G. D., Radok, P., Furuya, K., Hecht, S. S., Schut, H. A. J., and Klaunig, J. E. (1983) Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N‘-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues.Cancer Res.43, 1223−1229.
Morse, M. A., Amin, S. G., Hecht, S. S., and Chung, F.L. (1989) Effects of aromatic isothiocyanates on tumorigenicity,O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.Cancer Res.49, 2894−2897.
Smith T. J., 1990, Metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res. 50, 6817−6822
Pepin P., 1992, Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 13, 341−348
Bouchard L., 1993, Inhibitory effects of nonsteroidal antiinflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung explants. Drug Metab. Dispos. 21, 293−298
Guo Z., 1993, Growth, Dev., Aging, 57, 100
Shi S. T., 1994, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Res. 54, 4641−4647.
Jiao D., 1996, The essential role of the functional group 595 in alkyl isothiocyanates for inhibition of tobacco-nitrosamine-induced lung tumorigenesis. Carcinogenesis 17, 755−759
Pepin P., 1990, Cancer J., 3
Smith T., 1997, Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Carcinogenesis 18, 1577−1584
Castonguay A., 1983, Proc. Natl. Acad. Sci. U.S.A. 80
Smith T. J., 1992, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 52, 1757−1763
Staretz, M. E., Murphy, S. E., Nunes, M. G., Koehl, W., Amin, S., Koenig, L., Guengerich, F. P., and Hecht, S. S. (1997) Comparative metabolism of the tobacco smoke carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, andN‘-nitrosonornicotine in human hepatic microsomes.Drug Metab. Dispos.25, 154−162.
Smith T. J., 1995, Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res. 55, 5566−5573
Liu, Y., Sundqvist, K., Belinsky, S. A., Castonguay, A., Tjalve, H., and Grafstrom, R. C. (1993) Metabolism and macromolecular interaction of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in cultured explants and epithelial cells of human buccal mucosa.Carcinogenesis14, 2383−2388.
Collazo N. R., 1995, Biochem. Pharmacol. 50
Atawodi S. E., 1996, Bacterial reduction of N-oxides of tobacco-specific nitrosamines (TSNA). Human Exp. Toxicol. 15, 329−334
Anderson K. E., 1997, Metabolic activation of aromatic amines by human pancreas. Carcinogenesis 18, 1085−1092
Hecht S. S., 1997, Carcinogenesis 18
Prokopcyzk B., 1997, Proc. Am. Assoc. Cancer Res., 38, 340
Hecht S. S., 1990, Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 11, 1017−1020
Rivenson A., 1988, Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 48, 6912−6917
Patten, C. J., Smith, T. J., Murphy, S. E., Wang, M.H., Lee, J., Tynes, R. E., Koch, P., and Yang, C. S. (1996) Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.Arch. Biochem. Biophys.333, 127−138.
Lee V. M., 1996, An evaluation of the roles of metabolic denitrosation and alpha-hydroxylation in the hepatotoxicity of N-nitrosodimethylamine. Chem. Res. Toxicol. 9, 1319−1324
Guo Z., 1991, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system. Carcinogenesis 12, 2277−2282
Lacroix D., 1993, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Carcinogenesis 14, 1639−1642
Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.Carcinogenesis12, 1197−1201.
Islam S. A., 1991, A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. Carcinogenesis 12, 2211−2219
Yamazaki H., 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789−1794
Tiano H. F., 1993, Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 14, 1421−1427
Nesnow S., 1994, Mutat. Res., 324, 102
Smith T. J., 1996, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 17, 809−813
Duperron C., 1997, Chemoprevention efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis 18, 1001−1006
Code E., 1997, Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab. Dispos. 25, 985−993
Maser E., 1997, Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? TIPS 18, 270−275
Keefer L. K., 1987, Concurrent generation of methylamine and nitrite during denitrosation of N-nitrosodimethylamine by rat liver microsomes. Cancer Res. 47, 447−452
Wade D., 1987, Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes. Cancer Res. 47, 3373−3377
Adams J. D., 1985, On the pharmacokinetics of tobacco-specific N-nitrosamines in Fisher rats. Carcinogenesis 6, 509−511
Hecht S. S., 1986, Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46, 498−502
LaVoie E. J., 1987, Transfer of the tobacco-specific carcinogens N‘-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene into the milk of lacating rats. Carcinogenesis 8, 433−437
Prokopczyk G., 1987, Effect of snuff and nicotine on DNA methylation by 4-(methylnitrosamino)-1-3pyridyl-1-butanone. Carcinogenesis 8, 1395−1397
Morse M. A., 1823, Carcinogenesis 11, 1819
Schulze J., 1992, Carcinogenesis 13
Desai D., 1993, Identification of 4-(methylnitrosamino)-1-[3-(6-hydroxypyridyl)]-1-butanone as a urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat. Chem. Res. Toxicol. 6, 794−799
Richter E., 1994, Nicotine inhibits the metabolic activation of the tobacco-specific nitroamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Carcinogenesis 15, 1061−1064
Staretz M. E., 1995, Effects of phenethyl isothiocyanate on the tissue distribution of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites in F344 rats. Cancer Res. 55, 5580−5588
Hecht S. S., 1996, Carcinogenesis 17
Hecht S. S., 1996, Biomarkers Prev. 5, 645−652.
Hoffmann D., 1981, Cancer Res., 41, 2386
Castonguay A., 1985, Metabolism and tissue distribution of tobacco-specific N-nitrosamines in the marmoset monkey (Callithrix jacchus). Carcinogenesis 6, 1543−1550
Hecht, S. S., Trushin, N., Reid-Quinn, C. A., Burak, E. S., Jones, A. B., Southers, J. L., Gombar, C. T., Carmella, S. G., Anderson, L. M., and Rice, J. M. (1993) Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites.Carcinogenesis14, 229−236.
Idris A. M., 1992, Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis 13, 1001−1005
Carmella S. G., 1993, Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res. 53, 721−724
Murphy S. E., 1994, Biomarkers Prev. 3, 423−428.
Hecht S. S., 1995, Biomarkers Prev. 4, 877−884.
Carmella S. G., 1995, Biomarkers Prev. 4, 635−642.
Kresty L. A., 1996, Biomarkers Prev. 5, 521−525.
Carmella S. G., 1997, Biomarkers Prev. 6, 113−120.
Taioli E., 1997, Biomarkers Prev. 6, 517−522.
Meger M., 1996, Eur. J. Cancer Prev., 5
Hecht S. S., 1981, Comprehensive analysis of urinary metabolites of N‘-nitrosonornicotine. Carcinogenesis 2, 833−838
Hecht S. S., 1997, Proc. Am. Assoc. Cancer Res., 38, 463
Fay L. B., 1997, Urinary excretion of 3-methyladenine after consumption of fish containing high levels of dimethylamine. Carcinogenesis 18, 1039−1044
Stillwell W. G., 1991, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer. Cancer Res. 51, 190−194.
Prevost V., 1996, Cigarette smoking and urinary 3-alkyladenine excretion in man. Chem. Res. Toxicol. 9, 439−444
Kopplin A., 1995, Urinary excretion of 3-methyladenine and 3-ethyladenine after controlled exposure to tobacco smoke. Carcinogenesis 16, 2637−2641
Foiles, P. G., Trushin, N., and Castonguay, A. (1985) Measurement of O6-methyldeoxyguanosine in DNA methylated by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone using a biotin−avidin enzyme-linked immunosorbent assay.Carcinogenesis6, 989−993.
Castonguay A., 1985, Study of DNA methylation by tobacco-specific N-nitrosamines. Environ. Health Perspect. 62, 197−202
Hecht, S. S., Spratt, T. E., and Trushin, N. (1988) Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N‘-nitrosonornicotine.Carcinogenesis9, 161−165.
Spratt, T. E., Trushin, N., Lin, D., and Hecht, S. S. (1989) Analysis for N2-(pyridyloxobutyl)deoxyguanosine adducts in DNA of tissues exposed to tritium-labeled 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone andN‘-nitrosonornicotine.Chem. Res. Toxicol.2, 169−173.
Peterson L. A., 1991, Carcinogenesis 12
Peterson L. A., 1993, Pyridyloxobutyl DNA adducts inhibit the repair of O6-methylguanine. Cancer Res. 53, 2780−2785
Liu X.-K., 1996, Pyridyloxobutylation of guanine residues by 4-[(acetoxymethyl)nitrosamino]-1-(3-pyridyl)-1-butanone generates substrates of O6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 9, 949−953
Wang, L., Spratt, T. E., Lia, X.K., Hecht, S. S., Pegg, A. E., and Peterson, L. A. (1997) Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferase.Chem. Res. Toxicol.10, 562−567.
Loechler E. L., 1984, Proc. Natl. Acad. Sci. U.S.A. 81
Hecht S. S., 1983, Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 4, 305−310
Ronai, Z., Gradia, S., Peterson, L. A., and Hecht, S. S. (1993) G to A transitions and G to T transversions in codon 12 of the K-rasoncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents.Carcinogenesis14, 2419−2422.
Singer, B., and Grunberger, D. (1983)Molecular Biology of Mutagens and Carcinogens, pp 45−96, Plenum Press, New York.
Hecht, S. S., and Lin, D. (1986) Comparative mutagenicity of 4-(carbethoxynitrosamino)-4-(3-pyridyl)butanal and 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, model compounds for α-hydroxylation ofN‘-nitrosonornicotine.Carcinogenesis7, 611−614.
Peterson L. A., 1990, Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 11, 1329−1333
Spratt, T. E., Peterson, L. A., Confer, W. L., and Hecht, S. S. (1990) Solvolysis of model compounds for α-hydroxylation of N‘-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophiles.Chem. Res. Toxicol.3, 350−356.
Peterson L. A., 1991, O6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51, 5557−5564
Hecht S. S., 1988, DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 9, 1665−1668
Murphy S. E., 1990, Dose−response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 50, 5446−5452
Foiles P. G., 1991, Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol. 4, 364−368
Trushin N., 1994, Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco specific nitrosamines. Cancer Res. 54, 1205−1211
Staretz, M. E., Foiles, P. G., Miglietta, L. M., and Hecht, S. S. (1997) Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate.Cancer Res.57, 259−266.
Young-Sciame R., 1995, Reactions of α-acetoxy-N-nitrosopyrrolidine and α-acetoxy-N-nitrosopiperidine with deoxyguanosine: formation of N2-tetrahydrofuranyl or N2-tetrahydropyranyl adducts. Chem. Res. Toxicol. 8, 607−616
Wang M., 1995, Formation of N2-tetrahydrofuranyl and N2-tetrahydropyranyl adducts in the reactions of α-acetoxy-N-nitrosopyrrolidine and α-acetoxy-N-nitrosopiperidine with DNA. Chem. Res. Toxicol. 8, 617−624
Latif F., 1988, Styrene oxide as a stereochemical probe for the mechanism of aralkylation at different sites on guanosine. Chem. Res. Toxicol. 1, 364−369
Peterson L. A., 1993, Pyridyloxobutyl DNA adducts inhibit the repair of O6-methylguanine. Cancer Res. 53, 2780−2785
Castonguay A., 1984, N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer (O'Neill
Belinsky, S. A., White, C. M., Boucheron, J. A., Richardson, F. C., Swenberg, J. A., and Anderson, M. (1986) Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone.Cancer Res.46, 1280−1284.
Belinsky S. A., 1987, Cell-selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 47, 1143−1148
Belinsky, S. A., Walker, V. E., Maronpot, R. R., Swenberg, J. A., and Anderson, M. W. (1987) Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia.Cancer Res.47, 6058−6065.
Belinsky S. A., 1988, Cell specific differences in O6-methylguanine-DNA methyltransferase activity and removal of O6-methylguanine in rat pulmonary cells. Carcinogenesis 9
Morse, M. A., Wang, C.X., Amin, S. G., Hecht, S. S., and Chung, F.L. (1988) Effects of dietary sinigrin or indole-3-carbinol on O6-methylguanine-DNA-transmethylase activity and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA methylation and tumorigenicity in F344 rats.Carcinogenesis9, 1891−1895.
Morse, M. A., Wang, C.X., Stoner, G. D., Mandal, S., Conran, P. B., Amin, S. G., Hecht, S. S., and Chung, F.L. (1989) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in lung of F344 rats by dietary phenethyl isothiocyanate.Cancer Res.49, 549−553.
Belinsky, S. A., Foley, J. F., White, C. M., Anderson, M. W., and Maronpot, R. R. (1990) Dose−response relationship between O6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Cancer Res.50, 3772−3780.
Chung, F.L., and Xu, Y. (1992) Increased 8-hydroxydeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Carcinogenesis13, 1269−1272.
Liu L., 1992, Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 13, 2137−2140
Bianchini F., 1994, Comparison of 7medG formation in white blood cells, liver and target organs in rats treated with methylating carcinogens. Carcinogenesis 15, 1137−1141
Van Benthen J., 1994, O6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 15
Jansen, J. G., deGroot, A. J. L., van Teijlingen, C. M. M., Tates, A. D., Vrieling, H., and van Zeeland, A. A. (1996) Induction of hprt gene mutations in splenic T-lymphocytes from the rat exposed in vivo to DNA methylating agents is correlated with formation of O6-methylguanine in bone marrow and not in the spleen.Carcinogenesis17, 2183−2191.
Prokopczyk, B., Cox, J. E., Upadhyaya, P., Amin, S., Desai, D., Hoffmann, D., and El-Bayoumy, K. (1996) Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats.Carcinogenesis17, 749−753.
Belinsky S. A., 1989, The relationship between the formation of promutagenic adducts and the activation of the K-ras proto-oncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 49, 5305−5311
Hecht S. S., 1990, Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 11, 1017−1020
Devereux T. R., 1991, Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis 12, 299−303
Morse M. A., 1850, Cancer Res. 51, 1846
Xu Y., 1992, Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52, 3875−3879
Belinsky S. A., 1992, Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 52, 3164−3173
Devereux T. R., 1993, Comparison of pulmonary O6-methylguanine DNA adduct levels and K-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinog. 8, 177−185
Hecht S. S., 1987, Effects of α-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Carcinogenesis 8, 291−294
Hecht S. S., 1904, Carcinogenesis 10, 1901
Kato S., 1993, 7-Alkyldeoxyguanosine adduct detection by two-step HPLC and the 32P-postlabeling assay. Carcinogenesis 14, 545−550
Shields P. G., 1990, Combined high performance liquid chromatography/32P-postlabeling assay of N7 methyldeoxyguanosine. Cancer Res. 50, 6580−6584
Mustonen R., 1993, Smoking-related DNA adducts: 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis 14, 151−154
Blomeke B., 1996, Distribution of 7-alkyl-2‘-deoxyguanosine adduct levels in human lung. Carcinogenesis 17, 741−748
Alaoui-Jamali M. A., 1990, Mutat. Res., 240, 33
Demkowicz-Dobrzanski K., 1991, Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes. Carcinogenesis 12, 2135−2140
Pool-Zobel B. L., 1992, Systemic genotoxic effects of tobacco-related nitrosamines following oral and inhalational administration to Sprague−Dawley rats. Clin. Invest. 70, 299−306
Demkowicz-Dobrzanski K., 1991, Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes. Carcinogenesis 12, 2135−2140
Becher R., 1993, Chemically induced DNA damage in isolated rabbit lung cells. Mutat. Res. 285, 303−311
Joquera R., 1994, DNA single-strand breaks and toxicity induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or N-nitrosoimethylamine in hamster and rat liver. Carcinogenesis 15, 389−394
Weitberg A. B., 1997, J. Exp. Clin. Cancer Res., 16, 14
Ehrenberg L., 1980, Carcinog., Mutagen. 1, 105−127.
Skipper P. L., 1990, Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11, 507−518
Carmella S. G., 1987, Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N‘-nitrosonornicotine. Cancer Res. 47, 2626−2630
Carmella S. G., 1990, Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compounds. Cancer Res. 50, 5453−5459
Carmella S. G., 1990, Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res. 50, 5438−5445
Richter E., 1992, Tobacco-specific nitrosamines − metabolism and biological monitoring of exposure to tobacco products. Clin. Invest. 70, 290−294
Falter B., 1994, Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Invest. 72, 364−371
Melikian A. A., 1997, Biomarkers Prev. 6, 833−839.
Chen B., 1993, Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis 14, 1603−1608
Matzinger S. A., 1995, K-ras mutations in lung tumors from A/J and A/JxTSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 16, 2487−2492
Oreffo V. I. C., 1992, Mutational analysis of a dominant oncogene (c−K-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis. Mol. Carcinog. 6, 199−202
Oreffo, V. I. C., Lin, H.W., Padmanabhan, R., and Witschi, H. (1993) K-rasandp53point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors.Carcinogenesis14, 451−455.
Jiao, J., Zielenska, M., Anderson, M. W., and Glickman, B. W. (1991) Mutational specificities of environmental carcinogens in thelacI gene ofEscherichia coli: IV. The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Carcinogenesis12, 221−224.
Jiao, J., Guttenplan, J. B., Glickman, B. W., Anderson, M. W., Xin, L. Y., and Zielenska, M. (1993) Mutational specificities of environmental carcinogens in the lacl gene ofEscherichia coliVII: the host-mediated assay and its comparison with in vitro mutagenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.Mol. Carcinog.8, 127−131.
Tiano H. F., 1994, Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specifity in the gpt gene of AS52 cells. Carcinogenesis 15, 2859−2866
Belinsky S. A., 1991, Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. Exp. Lung Res. 17, 263−278
Westra W. H., 1996, K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 56, 2224−2228
Mills X. E., 1995, Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55, 1444−1447
Rodenhuis S., 1992, Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 52 (Supple.), 2665s−2669s
Westra W. H., 1993, K-ras oncogene activation in lung adenocarcinomas from former smokers. Cancer 72, 432−438
You M., 1989, Proc. Natl. Acad. Sci. U.S.A. 86
Singer B., 1991, Site-specific mutagenesis: retrospective and prospective. Carcinogenesis 12, 949−955
Moriya M., 1993, Proc. Natl. Acad. Sci. U.S.A. 90
Moriya M., 1994, Proc. Natl. Acad. Sci. U.S.A. 91
Nesnow S., 1995, Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology 103, 403−413, 10.1016/0300-483X(95)03238-B
Hecht S. S., 1986, Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46, 4162−4166
Lijinsky W., 1991, Vivo, 5, 89
Hoffmann D., 1993, Effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 53, 2758−2761
Nachiappan V., 1994, Lipid peroxidation and ethanol-related tumor promotion in Fischer-344 rats treated with tobacco-specific nitrosamines. Alcohol Alcohol. 29, 565−574
Boorman G. A., 1994, Toxicology and carcinogenesis studies of ozone and 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone in Fischer-344/N rats. Toxicol. Pathol. 22, 545−554
Chung F.-L., 1996, Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. Cancer Res. 56, 772−778
Morse, M. A., Eklind, K. I., Amin, S. G., Hecht, S. S., and Chung, F.L. (1989) Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates.Carcinogenesis10, 1757−1759.
Anderson L. M., 1989, Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Cancer Res. 49, 3770−3775
Wattenberg L. W., 1991, Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12, 115−117
Gunning W. T., 1991, Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol. Pathol. 19, 168−175
Castonguay A., 1991, Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp. Lung Res. 17, 485−499
Wang Z. Y., 1992, Cancer Res. 52
Boukharta M., 1992, Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer 18, 181−189
Belinsky S. A., 1993, The A/J mouse lung as a model for developing new chemointervention strategies. Cancer Res. 53, 410−416
El-Bayoumy, K., Upadhyaya, P., Desai, D. H., Amin, S., and Hecht, S. S. (1993) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate.Carcinogenesis14, 1111−1113.
Alworth W. L., 1993, Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P-450. Carcinogenesis 14, 1711−1713
Beebe, L. E., Kim, Y. E., Amin, S., Riggs, C. W., Kovatch, R. M., and Anderson, L. M. (1993) Comparison of transplacental and neonatal initiation of mouse lung and liver tumors byN- 600 nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254).Carcinogenesis14, 1545−1548.
Jiao D., 1994, Structure−activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res. 54, 4327−4333
Hecht, S. S., Isaacs, S., and Trushin, N. (1994) Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents.Carcinogenesis15, 2721−2725.
El-Bayoumy, K., Upadhyaya, P., Desai, D. H., Amin, S., Hoffmann, D., and Wynder, E. L. (1996) Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, andd-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung.Anticancer Res.16, 2709−2712.
Wattenberg, L. W., and Estensen, R. D. (1996) Chemopreventive effects ofmyo-mositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice.Cancer Res.56, 5132−5135.
Yang, G.Y., Wang, Z.Y., Kim, S., Liao, J., Serril, D. N., Chen, X., Smith, T. J., and Yang, C. S. (1997) Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice.Cancer Res.57, 1889−1894.
Castonguay A., 1997, Inhibition of lung tumorigenesis by sulindac: comparison of two protocols. Carcinogenesis 18, 491−496
Hecht, S. S., Adams, J. D., Numoto, S., and Hoffmann, D. (1983) Induction of respiratory tract tumors in Syrian golden hamsters by a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the effect of smoke inhalation.Carcinogenesis4, 1287−1290.
Padma P. R., 1989, Carcinogenesis 10
Correa E., 1990, The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res. 50, 3435−3438
Schüller H. M., 1990, Cancer Res. 50
Park N.-H., 1993, NIH Publ. No. 93-3461, 215
Schüller H. M., 1993, Transplancental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 53, 2498−2501
Schüller H. M., 1994, J. Cancer Res. Clin. Oncol., 120
Chen Y.-P., 1994, J. Oral Pathol. Med., 23
Sunday M. E., 1995, Am. J. Pathol., 147
Furukawa F., 1997, Promotional effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) on N-nitrosobis (2-oxopropyl) amine (BOP)-initiated carcinogenesis in hamsters. Food Chem. Toxicol. 35, 387−392
Hecht S. S., 1997, Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect. 105, (Suppl. 4), 955−963
Prokopczyk B., 1997, Carcinogenesis 18
Hawk M. A., 1996, Cancer Lett., 109
Bilodeau J.-F., 1995, Free Radicals Biol. Med., 18, 54
Padma P. R., 1989, Antimutagenic effects of betel leaf extract against the mutagenicity of two tobacco-specific N-nitrosamines. Mutagenesis 4, 154−156
Amonkar A. J., 1989, Protective effect of hydroxychavicol, a phenolic component of betel leaf against the tobacco-specific carcinogens. Mutat. Res. 210, 249−253
Dahl, J. E., Becher, R., Låg, M., Schuller, H. M., and Dybing, E. (1990) Formation of genotoxic products fromN-nitrosoheptamethyleneimine (NHMI), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N‘-nitrosonornicotine (NNN) by isolated rabbit lung cells.Cell Biol. Toxicol.6, 399−409.
Zhu S. Y., 1991, Cytotoxicity, genotoxicity and transforming activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat tracheal epithelial cells. Mutat. Res. 261, 249−259
Teel R. W., 1992, Cancer Lett., 66
Teel, R. W. (1992) Effect of different inducers of cytochrome P450 on the mutagenesis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) inSalmonella typhimuriumTA1535.Anticancer Res.12, 1287−1290.
Romert L., 1992, Chlorophyllin is both a positive and negative modifier of mutagenicity. Mutagenesis 7, 349−355
Espinosa-Aguirre J. J., 1993, Antimutagenicity of cyclohexanol towards 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone and N-nitrosodiethylamine. Mutat. Res. 300, 151−154
Teel, R. W. (1993) Effect of phytochemicals on the mutagenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) inSalmonella typhimuriumstrain TA1535.Phytother. Res.7, 248−251.
DeFlora S., 1995, Mutagenesis, 10, 52
Lee C. K., 1996, Mutat. Lett., 367, 92
Alaoui-Jamali M. A., 1988, vitro genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone activated by hamster maternal and fetal tissues. Carcinogenesis 9, 2319−2324
Zimonjic D., 1989, Induction of sister-chromatid exchanges by tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human and hamster cells. Carcinogenesis 10, 753−755, 10.1093/carcin/10.4.753
Pohlmann, C., Koops, F., Berg, J., Holz, O., Ehlert, U., and Rüdiger, H. W. (1992) Determinants of a genotoxic effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human diploid fibroblasts.Clin. Invest.70, 295−298.
Swedmark S., 1994, Comparison of co-cultivation of V79 cells with rat hepatocytes and rat H4IIE hepatoma cells for studying nitrosamine-induced hprt gene mutations. Mutagenesis 9, 281−287, 10.1093/mutage/9.4.281
Knasmuller, S., Kassie, F., Zohrer, E., Kundi, M., McCoy, G. D., and Schulte-Hermann, R. (1994) Effects of ethanol treatment on DNA damage induced inEscherichia coliK-12 in various organs of mice byN-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone andN-nitrosopyrrolidine.Carcinogenesis15, 263−270.
Kim, P. M., and Wells, P. G. (1996) Genoprotection by UDP-glucucuronyltransferases in perioxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene.Cancer Res.56, 1526−1532.
Hellman B., 1985, Tissue-specific inhibition of [3H]thymidine incorporation into DNA by carcinogenic N-nitrosamines. Mutat. Res. 149, 495−503
Zhu S., 1992, The effect of sodium selenate on cell proliferation and transformation of primary rat tracheal epithelial cells. Carcinogenesis 13, 1725−1729
Klein-Szanto A. J. P., 1992, Proc. Natl. Acad. Sci. U.S.A. 89
Baskaran K., 1994, Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis 15, 2461−2466
Langenfeld J., 1996, Oncogene 13
Tjälve H., 1985, J. Natl. Cancer Inst., 74
Hoss W., 1986, Characterization of noncholinergic nicotine receptors on human granulocytes. Biochem. Pharmacol. 35, 2367−2372
Schüller H., 1989, Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem. Pharmacol. 38, 3439−3439
Schüller H. M., 1989, Regulation of cell proliferation by β-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis 10, 1753−1755
Padma P. R., 1991, Effect of long-term treatment of two tobacco-specific N-nitrosamines on the vitamin A status of mice. Nutr. Cancer 15, 217−220
Murrah V. A., 1993, Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg. Oral Med. Oral Pathol. 75, 324−332
Sunday M. E., 1994, Modulation of oncogene and tumor suppression gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasis. Lab. Invest. 70, 875−888
Schüller H. M., 1994, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways. Neurotoxicology 15, 877−886.
Hu G., 1995, Inhibition of oncogene expression by green tea and (−)-epigallocatechin gallate in mice. Nutr. Cancer. 24, 203−209
Issa J.-P. J., 1996, Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res. 56, 3655−3658
Lyng F. M., 1996, Effect of a tobacco-related nitrosamine on intercellular communication in human urothelial cells: a possible factor in smoking-related bladder carcinogenesis. Oncol. Res. 8, 371−378
Penn A., 1996, 1,3-Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation 93, 552−557
Belinsky S. A., 1997, Deletion and differential expression of
Dokko, H., Min, P. S., Cherrick, H. M., and Park, N.H. (1991) Effect of smokeless tobacco and tobacco-related chemical carcinogens on survival of ultraviolet light-inactivated herpes simplex virus.Oral Surg. Med. Oral Pathol.71, 464−468.
Park N.-H., 1991, J. Oral Maxillofac. Surg., 49
Larsson P.-A., 1992, Inhibition of Herpes simplex virus replication and protein synthesis by nonsmoked tobacco, tobacco alkaloids and nitrosamines. Arch. Oral Biol. 37, 969−978
Kim, M. S., Shin, K.H., Baek, J.H., Cherrick, H. M., and Park, N.H. (1993) HPV-16, tobacco-specificN-nitrosamine, andN-methyl-N‘-nitro-N-nitrosoguanidine in oral carcinogenesis.Cancer Res.53, 4811−4816.
Lindemann, R. A., and Park, N.H. (1989) The effects of benzo[a]pyrene, nicotine and tobacco-specific N-nitrosamines in the generation of human lymphokine-activated killer cells.Arch. Oral Biol.34, 283−287.
Chen C. B., 1978, N‘-nitrosonornicotine. Cancer Res. 38, 3639−3645.
Chen C. B., 1979, Assay for microsomal α-hydroxylation of N‘-nitrosonornicotine and determination of the deuterium isotope effect for α-hydroxylation. Cancer Res. 39, 5057−5062
McCoy G. D., 1981, Influence of mixed function oxidase inducers on the in vitro metabolism of N‘-nitrosonornicotine by rat and hamster liver microsomes. Drug Metab. Dispos. 9, 168−169
Hecht S. S., 1982, Metabolism of N‘-nitrosonornicotine by cultured rat esophagus. Carcinogenesis 3, 453−456
Hecht S. S., 1982, N‘-nitrosonornicotine and N‘-nitrosoanabasine. Carcinogenesis 3, 1195−1199.
Chung F.-L., 1984, Effects of dietary compounds on α-hydroxylation of N-nitrosopyrrolidine and N‘-nitrosonornicotine in rat target tissues. Cancer Res. 44, 2924−2928
Castonguay A., 1984, Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N‘-nitrosonornicotine in F344 rats. Cancer Res. 44, 2285−2290
Murphy S. E., 1994, Evidence for a high affinity enzyme in rat esophageal microsomes which α-hydroxylates N‘-nitrosonornicotine. Carcinogenesis 15, 2709−2713
Autrup H., 1978, Proc. Soc. Exp. Biol. Med. 159
Hecht S. S., 1979, Cancer Lett., 8, 41
Patten C., 1997, Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N‘-nitrosonornicotine α-hydroxylation by human liver microsomes. Carcinogenesis 18, 1623−1630
Egashira T., 1984, Histochemical localization of monoamine oxidase in whole-body, freeze-dried sections of mice. Histochemistry 16, 919−929
McCoy G. D., 1982, N-Nitroso Compounds: Occurrence and Biological Effects (Bartsch, H., O'Neill
Nakajima M., 1996, Role of human cytochrome P450 2A6 in C-oxidation of nicotine. Drug Metab. Dispos. 24, 1212−1217
Egashira T., 1984, Histochemical localization of primary and secondary alcohol dehydrogenases in whole-body, freeze-dried sections of mice. Histochemistry 16, 931−940
Brittebo E. B., 1981, Formation of tissue-bound N‘-nitrosonornicotine metabolites by the target tissues of Sprague−Dawley and Fisher rats. Carcinogenesis 2, 959−963
Löfberg B., 1982, Localization and binding of N‘-nitrosonornicotine metabolites in the nasal region and in some other tissues of Sprague−Dawley rats. Cancer Res. 42, 2877−2883
Waddell W. J., 1980, Localization of [14C]nitrosonornicotine in tissues of the mouse. Cancer Res. 40, 3518−3523
Domellöf L., 1987, Distribution and metabolism of N‘-nitrosonornicotine in the miniature pig. Carcinogenesis 8, 1741−1747
Chung F.-L., 1989, Cancer Res. 49
Wang M., 1992, Carcinogenesis 13
Wang M., 1997, C-8 guanine adduct of N-nitrosopyrrolidine (NPYR): formation in nucleic acids and excretion in the urine of NPYR-treated rats. Chem. Res. Toxicol. 10, 772−778.
Lai D. Y., 1980, Res. Commun. Chem. Pathol. Pharmacol., 28, 103
Diaz Gómez M. I., 1986, J. Natl. Cancer Inst., 76
Hecht S. S., 1982, N-Nitroso Compounds: Occurrence and Biological Effects (Bartsch, H., O'Neill
Hoffmann D., 1976, Environmental N-Nitroso Compounds: Analysis and Formation
Deutsch-Wenzel R. P., 1985, Cancer Lett., 29, 92
McCoy G. D., 1981, Differential effect of chronic ethanol consumption on the carcinogenicity of N-nitrosopyrrolidine and N‘-nitrosonornicotine in male Syrian golden hamsters. Cancer Res. 41, 2849−2854
Hecht S. S., 1983, Cancer Lett., 20
Koppang N., 1992, Carcinogenesis 13
Andrews A. W., 1978, The relationship between mutagenicity and carcinogenicity of some nitrosamines. Mutat. Res. 51, 319−326
Bartsch H., 1980, Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals. IARC Scientif. Publ. 27, 179−241
Gruetter C. A., 1980, J. Pharmacol. Exp. Ther., 214, 15
Olson J. W., 1985, Effect of nicotine and N‘-nitrosonornicotine on rat lung and trachea ornithine decarboxylase activity. Carcinogenesis 6, 1517−1519
Schuster G. S., 1986, Oral epithelial cell lipid synthesis in the presence of retinoic acid or nitrosonornicotine. Oral Pathol. 15, 430−433
Schuster G. S., 1988, Cytobios, 54, 60
Ammigan N., 1990, Indian J. Exp. Biol., 28
Schuster G., 1995, Vitro Cell. Dev. 31, 295−299.
Djordjevic M. V., 1989, Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco. Carcinogenesis 10, 1725−1731
Tricker A. R., 1993, Evaluation of 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites. Carcinogenesis 14, 1409−1414
Ross, J. A., Nelson, G. B., Wilson, K. H., Rabinowitz, J. R., Galati, A., Stoner, G. D., Nesnow, S., and Mass, M. J. (1995) Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.Cancer Res.55, 1039−1044.
Deutsch-Wenzel R., 1983, J. Natl. Cancer Inst., 71
Wolterbeek A. P. M., 1995, Cancer Lett., 89
Gerde P., 1997, Carcinogenesis 18
Alexandrov K., 1992, An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers
Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in thep53tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.Cancer Res.54, 4855−4878.
Denissenko M. F., 1996, Preferential formation of benzo[a]pryene adducts at lung cancer mutational hot spots in P53. Science 274, 430−432
Hoffmann D., 1993, J. Smoking-Related Disorders, 4
Devesa S. S., 1991, Cancer Epidemiol., Biomarkers Prev., 1, 34
Carmella S., 1997, Evidence for endogenous formation of tobacco-specific nitrosamines from nicotine and other tobacco alkaloids in rats. Carcinogenesis 18, 101−106
Österdahl B.-G., 1990, The migration of tobacco-specific nitrosamines into the saliva of chewers of nicotine-containing chewing gum. Food Chem. Toxicol. 28, 619−622
Parsons W. D., 1998, Biomarkers Prev. 7, 257−260.
Perera F. P., 1997, Environment and cancer: who are susceptible? Science 278, 1068−1073
Abbreviations AGT, alanine transaminase